Zurueck zur Suche

Reporte zur Charge UT7729BA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

18Reporte angezeigt
2Todesfaelle
6Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
MI 8 NY 3 OH 2 IL 2 VA 1 IN 1 MA 1

VAERS 2557572

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

kritisch
Staat
MI
Alter
88,0
Geschlecht
M
Eingang
02.02.2023
Impfdatum
23.09.2022
Beginn
13.01.2023
Tage bis Beginn
112,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Agitation Arthralgia Back pain COVID-19 COVID-19 pneumonia Asthenia Confusional state Disorientation SARS-CoV-2 test positive Computerised tomogram head normal Computerised tomogram neck Computerised tomogram spine Death Delirium Dysphagia Epiglottitis Fall Fracture

Symptomtext

Discharge Provider: MD Primary Care Physician at Discharge: DO Admission Date: 1/13/2023 PRESENTING PROBLEM: Compression fracture of L5 lumbar vertebra, closed, initial encounter [S32.050A] Compression fracture of L5 vertebra, initial encounter [S32.050A] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Patient was a 88-year-old man who presents to the hospital with COVID-19 infection causing pneumonia. He started having frequent falls. He then developed severe back pain and presented to the emergency department on 01/13. He was found to have L5 superior endplate compression fracture. He was started on Lyrica, Flexeril and oxycodone. He was awaiting rehab placement since he was in quarantine for COVID-19. On the morning of 1/18 he was found on the floor. CT head was negative. X-ray of right shoulder done secondary to pain was negative. On that day he seems slightly confused. Oxycodone was discontinued and changed to Norco. He started to require Zyprexa for confusion and agitation. Norco and Lyrica were then discontinued. The patient had another fall on 01/19. CT head was repeated and negative. CT lumbar spine repeated show worsening of the previous L5 compression fracture. He started to develop delirium. He then started to have decreased oral intake. He started complaining of throat pain and was unable to swallow. Strep swab was collected and negative. Due to continued severe pain and inability to swallow, CT neck with contrast was performed which revealed epiglottitis. I spoke with family about his poor oral intake, very low body mass index and concern for failure to thrive. Patient decided to convert to comfort care measures only. He was placed on sublingual morphine and passed away peacefully with his family at bedside. Time of death 4:09 p.m. on 01/25/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
CAD (coronary artery disease) Diverticulosis H/O recurrent pneumonia History of tobacco abuse Gastroesophageal reflux disease Carotid disease, bilateral Elevated serum alkaline phosphatase level Esophageal stricture Depression MCI (mild cognitive impairment) Protein-calorie malnutrition, moderate Glaucoma Hypercholesterolemia HTN (hypertension), benign History of sputum culture for ESBL E. coli Macrocytic anemia Macular degeneration of both eyes, unspecified type History of esophageal ulcer History of bladder cancer Accidental perforation of bladder during operative procedure Weakness Compression fracture of L5 lumbar vertebra, closed, initial encounter COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 325 MG tablet aspirin 325 MG tablet atorvastatin (LIPITOR) 80 MG tablet B Complex Vitamins (VITAMIN B COMPLEX) TABS betaxolol (BETOPTIC-S) 0.25 % ophthalmic suspension Bimatoprost (LUMIGAN) 0.01 % citalopram (CELEXA)
Allergien
None
Vorherige Impfungen
-

VAERS 2557572

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

kritisch
Staat
MI
Alter
88,0
Geschlecht
M
Eingang
02.02.2023
Impfdatum
23.09.2022
Beginn
13.01.2023
Tage bis Beginn
112,0
Dosis
N/A
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Agitation Arthralgia Back pain COVID-19 COVID-19 pneumonia Asthenia Confusional state Disorientation SARS-CoV-2 test positive Computerised tomogram head normal Computerised tomogram neck Computerised tomogram spine Death Delirium Dysphagia Epiglottitis Fall Fracture

Symptomtext

Discharge Provider: MD Primary Care Physician at Discharge: DO Admission Date: 1/13/2023 PRESENTING PROBLEM: Compression fracture of L5 lumbar vertebra, closed, initial encounter [S32.050A] Compression fracture of L5 vertebra, initial encounter [S32.050A] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Patient was a 88-year-old man who presents to the hospital with COVID-19 infection causing pneumonia. He started having frequent falls. He then developed severe back pain and presented to the emergency department on 01/13. He was found to have L5 superior endplate compression fracture. He was started on Lyrica, Flexeril and oxycodone. He was awaiting rehab placement since he was in quarantine for COVID-19. On the morning of 1/18 he was found on the floor. CT head was negative. X-ray of right shoulder done secondary to pain was negative. On that day he seems slightly confused. Oxycodone was discontinued and changed to Norco. He started to require Zyprexa for confusion and agitation. Norco and Lyrica were then discontinued. The patient had another fall on 01/19. CT head was repeated and negative. CT lumbar spine repeated show worsening of the previous L5 compression fracture. He started to develop delirium. He then started to have decreased oral intake. He started complaining of throat pain and was unable to swallow. Strep swab was collected and negative. Due to continued severe pain and inability to swallow, CT neck with contrast was performed which revealed epiglottitis. I spoke with family about his poor oral intake, very low body mass index and concern for failure to thrive. Patient decided to convert to comfort care measures only. He was placed on sublingual morphine and passed away peacefully with his family at bedside. Time of death 4:09 p.m. on 01/25/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
CAD (coronary artery disease) Diverticulosis H/O recurrent pneumonia History of tobacco abuse Gastroesophageal reflux disease Carotid disease, bilateral Elevated serum alkaline phosphatase level Esophageal stricture Depression MCI (mild cognitive impairment) Protein-calorie malnutrition, moderate Glaucoma Hypercholesterolemia HTN (hypertension), benign History of sputum culture for ESBL E. coli Macrocytic anemia Macular degeneration of both eyes, unspecified type History of esophageal ulcer History of bladder cancer Accidental perforation of bladder during operative procedure Weakness Compression fracture of L5 lumbar vertebra, closed, initial encounter COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 325 MG tablet aspirin 325 MG tablet atorvastatin (LIPITOR) 80 MG tablet B Complex Vitamins (VITAMIN B COMPLEX) TABS betaxolol (BETOPTIC-S) 0.25 % ophthalmic suspension Bimatoprost (LUMIGAN) 0.01 % citalopram (CELEXA)
Allergien
None
Vorherige Impfungen
-

VAERS 2543266

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

kritisch
Staat
OH
Alter
73,0
Geschlecht
F
Eingang
26.12.2022
Impfdatum
11.12.2022
Beginn
19.12.2022
Tage bis Beginn
8,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cerebrovascular accident

Symptomtext

Caregiver called and stated that patient had a stroke on 12/19/22 and was concerned it could be related to the vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2525525

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

kritisch
Staat
NY
Alter
88,0
Geschlecht
F
Eingang
07.12.2022
Impfdatum
19.10.2022
Beginn
21.10.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Asthenia Dysstasia Gait inability Impaired self-care Intensive care Laboratory test Malaise Mobility decreased Myocardial infarction Walking aid user

Symptomtext

She got her vaccine, she didn't have any reaction until the next day when her family could not reach her and they sent somebody to help her, they could hear her but could not get up, and they found her on the floor, like a dishrag, no strength, could not move, could not stand, could not dial the phone, could not answer the door. She could yell but they could not hear her. The fire Department broke the door down and rescued her. They took her to Community Hospital. She was put in ICU, saw a cardiologist who said that she had a heart attack, and her personal cardiologist said he did not feel it was a heart attack as she had just been tested and it was fine. She was then sent to rehab and was there for over a month. She went around 9/30/22 to 10/1/22, and she got home last Monday, 11/28/22. She is far from well, she has a cane, walker, hospital bed and is still suffering. She did use a cane for sporadic flare up for arthritis of her knee. She wants to walk upright and be as she was prior to the vaccine. She did regain her strength and is able to walk which she did not feel she would walk again. She is on multiple medicines now and has appointments with doctors. She is going to her cardiologist tomorrow. She now has to have an aide to assist her as she is not able to clean herself and not able to take care of herself. She is also having home therapy come and assist her with mobility. The rehab unit she was in was Rehab Center.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
9,0
Labordaten
Multiple while in the hospital and rehab.
Aktuelle Erkrankungen
None.
Vorgeschichte
Pacemaker, high blood pressure, A-fib, hypothyroidism.
Andere Medikamente
Synthroid, Valsartan HCTZ, Eliquis, Vitamin D.
Allergien
Cat hair, dog hair, latex, contrast dye.
Vorherige Impfungen
-

VAERS 2711553

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

moderat
Staat
MI
Alter
92,0
Geschlecht
M
Eingang
08.11.2023
Impfdatum
22.09.2022
Beginn
20.07.2023
Tage bis Beginn
301,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Adult failure to thrive Asthenia COVID-19 Chest X-ray abnormal Computerised tomogram head normal Condition aggravated Fall Haemoglobin Lung disorder SARS-CoV-2 test positive Spinal X-ray abnormal Spinal compression fracture Thoracic vertebral fracture Urine analysis normal

Symptomtext

BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 7/20/2023 Discharge Date: 7/22/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Failure to thrive in adult [R62.7] COVID-19 virus detected [U07.1] HOSPITAL COURSE: Patient presented to the emergency department on 7/20/23 with complaint of weakness and fall at home. He was also utilizing his PRN oxygen more than normal. In the ER vital signs were stable with appropriate oxygen saturations on room air. Initial labs showed relatively unremarkable CMP, hemoglobin 12.9. He tested positive for COVID-19 in the ER. A UA was negative. A CT head was negative for acute intracranial hemorrhage. Chest x-ray showed chronic coarse lung markings but otherwise no acute findings. X-ray of the lumbar spine showed severe compression fracture at T9 which was progressed from 11/18/2022. Patient received a total of 1 L normal saline in the ER and was admitted to the hospitalist service for further management of weakness, COVID-19, and T9 compression fracture. For the compression fracture at T9, case was discussed with Dr. of Ortho Spine and he recommended no further intervention or brace at this time and out patient follow up as needed. During hospitalization, he remained on room air. PT/OT recommended SAR due to continued weakness and risk for fall. Unfortunately, patient was unwilling to go to COVID appropriate SAR facility due to distance from home. Remainder of chronic medical conditions remained stable. Today, he was in bed during examination. Please see today's progress note for examination and further information. Patient has opted for discharge home with home PT/OT which was arranged by care management. Family and patient understand risks due to his continued generalized weakness which includes additional falls. Please see discharge instructions for further information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Osteoarthritis of right shoulder Status post reverse total shoulder replacement, right Abdominal aortic aneurysm without rupture (HCC) Body mass index (BMI) of 20 to 24 Chronic obstructive pulmonary disease (HCC) ECG: old myocardial infarction Hypertension Peripheral vascular disease (HCC) Late effects of cerebrovascular disease Lumbosacral spondylosis without myelopathy Macrocytosis Mass of skin Mixed hyperlipidemia Seborrheic keratosis Sensorineural hearing loss, bilateral Squamous cell carcinoma of skin Stage 3a chronic kidney disease (HCC) Preop examination COVID-19 Weakness Fall Paroxysmal atrial fibrillation (HCC) Compression fracture of T9 vertebra (HCC) Anemia
Andere Medikamente
albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler cetirizine (ZYRTEC) 10 MG tablet DULERA 100-5 MCG/ACT AERO hydrochlorothiazide (HYDRODIURIL) 25 MG tablet methocarbamol (ROBAXIN) 750 MG tablet metoprolol
Allergien
None
Vorherige Impfungen
-

VAERS 2566808

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7729BA

moderat
Staat
MI
Alter
85,0
Geschlecht
M
Eingang
24.01.2023
Impfdatum
23.09.2022
Beginn
17.01.2023
Tage bis Beginn
116,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia Blood creatinine normal COVID-19 Condition aggravated Cough Diabetic foot Diarrhoea Dizziness Glomerular filtration rate Hyperglycaemia Hypoglycaemia Insulin therapy Metabolic acidosis Metabolic function test abnormal Nausea Oxygen saturation decreased Renal impairment SARS-CoV-2 test positive

Symptomtext

COVID+ 1/17/2023. Vaccination status - Moderna x4 + Moderna BIVALENT booster Discharge Summary MD (Physician) ? ? General Medicine BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/17/2023 Discharge Date: 01/19/2023 Active Hospital Problems Diagnosis Date Noted POA ? Diabetic ulcer of right midfoot associated with type 2 diabetes mellitus, with fat layer exposed 01/18/2023 Yes ? COVID 01/17/2023 Yes ? Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin Active Issues Requiring Follow-up: T2DM Diabetes Discharge Planning: ? The patient's wife is receiving OmniPod some time this week and will transition from V-Go which should make controlling his blood sugars easier. Should follow with outpatient provider to have this set up and pt/wife be trained in its use ? Transition back to V-GO not advised, as the patient's wife informed provider that pt has multiple episodes of hypoglycemia at home if he does not eat before bed + early in morning. Discharge Plan: ? Safe for discharge to home with ordered medication doses. Do not resume Vgo. Pt to start Omnipod when able/trained. ? Metformin use questionable in this pt due to age and declining renal function. However his dosage is within the perimeters of his reduced GFR (500mg twice daily), will need close monitoring by PCP. ? SGLT2 would be indicated due to CKD. This can cause fluctuations in glucose levels and would likely need insulin regimen adjustments Chronic Wounds ? DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID HOSPITAL COURSE: Patient is a 85 y.o. male who presented with weakness, nausea, vomiting, diarrhea, lightheadedness x 2 days duration. He developed a cough so wife administered a COVID-19 test which was positive. He reported ongoing symptoms on adm. They are concerned about him going home with these symptoms, as his primary caregiver / spouse is also sick with COVID-19 and feeling unwell. Hemodynamically stable in the ED, desaturation on room air. Mild metabolic acidosis on CMP with creatinine at baseline. No leukocytosis. One hypoglycemic reading with three other normal readings. +covid-19 pcr. No cxr. Given 500cc NS once and dextrose in ED. He was weaned off supplemental o2 and evaluated by pulm rehab/pt/ot who stated patient would need home with pt but no oxygen on discharge. His course was complicated by hypoglycemic episodes after patient refused to remove his insulin pump on admission. Once pump removed from patient, consulted for labile glucose levels. He had adjustments made in his diabetes medications and had improvement in glu levels. He was discharged home in stable conditions with plans for close follow up and teaching of upcoming diabetes medication changes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
Inpt 8/26/22-8/31/22: Admission Date: 8/26/2022 Discharge Date: 08/31/2022 Admitting Physician: MD Attending Physician: MD Discharge Clinician: MD Primary Care Provider at Discharge: MD Active Hospital Problems Diagnosis Date Noted POA ? Diabetic ulcer of left foot associated with type 2 diabetes mellitus, unspecified part of foot, unspecified ulcer stage Patient was started on IV vancomycin and Zosyn after blood cultures collected. Podiatry consulted and =ultimately performed partial left hallux amputation with likely surgical cure. Dr of Podiatry will follow cultures and follow-up with patient. Discharged home on keflex for 7 days. Patient was continued on his insulin pump during this hospital stay.
Vorgeschichte
Personal history of prostate cancer CAD (coronary artery disease) Hypertension associated with diabetes Diabetic infection of right foot Mixed hyperlipidemia Persistent atrial fibrillation Stage 3 chronic kidney disease Ischemic cardiomyopathy OSA (obstructive sleep apnea) Atherosclerosis of artery of both lower extremities Carotid artery stenosis Ischemic cerebrovascular accident (CVA) Obesity (BMI 30-39.9) ICD (implantable cardioverter-defibrillator) in place Atherosclerosis of native artery of right lower extremity with ulceration of midfoot RLS (restless legs syndrome) Syncope, unspecified syncope type Presence of Watchman left atrial appendage closure device Aortic stenosis Chronic systolic heart failure Polyneuropathy associated with underlying disease Abnormal CBC Platelets decreased Other constipation Difficulty with CPAP full face mask use Diabetic foot infection Atherosclerosis of native arteries of left leg with ulceration of other part of foot Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin
Andere Medikamente
Aspirin 81 mg Oral Daily B Complex Vitamins 1 tablet Oral Daily Bacillus Coagulans-Inulin 1-250 BILLION-MG 1 Caplet Oral Daily Cinnamon 2,000 mg Oral Daily Coenzyme Q10 100 mg Oral Daily Empagliflozin 25 mg Oral Daily Furosemide 20 mg Oral
Allergien
Adhesive TapeRash
Vorherige Impfungen
-

VAERS 2465813

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

moderat
Staat
OH
Alter
80,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
24.09.2022
Beginn
25.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain Injection site swelling Mobility decreased Muscular weakness

Symptomtext

Patient reports that started Sunday afternoon her right arm lost a muscle control that she had a hard time moving and area of injection was swollen and painful. She states that symptoms that she experienced were gone on Wednesday afternoon and her arm function came back as normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes, Hypertension , hyperlipidemia
Andere Medikamente
Metformin, Microzide, Zocor, Vitamin D3, Cyanocobalamin 100 mcg, Cozaar, Multivitamin. Trazodone, atenolol, Aspirin, Calcium
Allergien
Opioids, PCN, Sulfa
Vorherige Impfungen
-

VAERS 2587355

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

mild
Staat
NY
Alter
67,0
Geschlecht
F
Eingang
25.02.2023
Impfdatum
02.02.2023
Beginn
22.02.2023
Tage bis Beginn
20,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

On Feb 22, 2023, patient asked if "normal: for her arm to still hurt after getting a fly shot on 2-2-23. Advised patient to see her physician because pain usually subsides after 2 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2494122

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

mild
Staat
VA
Alter
67,0
Geschlecht
F
Eingang
31.10.2022
Impfdatum
27.10.2022
Beginn
27.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asthenia Feeling abnormal Pain Pain in extremity

Symptomtext

Patient reports shooting pain through arm, continual soreness, weakness, and feeling her arm is "not right"; Told patient should be seen by the doctor if symptoms do not improve/ if they get worse.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2491549

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut7729BA

mild
Staat
IN
Alter
67,0
Geschlecht
M
Eingang
27.10.2022
Impfdatum
22.09.2022
Beginn
01.10.2022
Tage bis Beginn
9,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration Musculoskeletal stiffness Pain in extremity Shoulder injury related to vaccine administration

Symptomtext

Pt had SIRVA from a vaccine that was given too high, and is complaining of muscle stiffness and arm pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2483082

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

mild
Staat
MA
Alter
81,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
04.10.2022
Beginn
05.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity X-ray

Symptomtext

patient reported pain in L arm after injection and was seen by her PCP office where they did testing to assess injury including x-ray. continues to have pain at this time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
x-ray
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472692

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

mild
Staat
IL
Alter
66,0
Geschlecht
M
Eingang
08.10.2022
Impfdatum
06.10.2022
Beginn
07.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site rash Injection site warmth Rash

Symptomtext

Rash, intense itching, redness, warmth to touch. Area affected include injection site, however it now spreads and includes area under both breasts.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
High BP
Andere Medikamente
-
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2468766

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

mild
Staat
NY
Alter
74,0
Geschlecht
F
Eingang
04.10.2022
Impfdatum
01.10.2022
Beginn
02.10.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fall Rash Wound

Symptomtext

Patient fell on the left side of her arm. At the same time there may be a rash at the side. Sounds relatively bubbling and wounded. Office was seen and prescribed Levofloxacin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Seen provider at office on 10/4/22
Aktuelle Erkrankungen
N/A
Vorgeschichte
Renal Abnormalities, Lupus Eryhtematosus, Rheumatoid Arthritis, Depression
Andere Medikamente
Methotrexate, Nortriptyline, Tramadol, Levothyroxine, Folic acid, Aricept
Allergien
Codeine, Tetracyclines and related
Vorherige Impfungen
-

VAERS 2465743

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut7729ba

mild
Staat
IL
Alter
75,0
Geschlecht
M
Eingang
30.09.2022
Impfdatum
22.09.2022
Beginn
24.09.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Gait disturbance Hyperhidrosis Laboratory test normal Vertigo Vomiting

Symptomtext

Patient stated approximately 2 days after vaccines experienced vertigo, excessive sweating, vomiting, loss of stability. So much so he went to the hospital, and he was there from Sat to Tues. He said from the tests ran etc certain things were ruled out and it seemed that he was experiencing these symptoms due to the vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
mesalamine 1.2gm also received the high dose flu shot at the same time of covid moderna booster
Allergien
milk products,nsaid,corticosteroids
Vorherige Impfungen
-

VAERS 2502859

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
09.11.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

under the age of 65 receive fluzone high dose in error, with no reported adverse event; Initial information received on 27-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA448810(CLUSTER). This case involves Adult and unknown gender patient who is under the age of 65 received influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] in error with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient under the age of 65 received a dose of suspect influenza quadrival A-B high dose HV vaccine (lot UT7729BA; Expiration Date: 30-Jun-2023) via unknown route in unknown administration site for immunization in error with no reported adverse event (product administered to patient of inappropriate age). Action taken: not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2498805

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
04.11.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

receive Fluzone High Dose in error with no reported adverse event; Initial information received on 27-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 3 adult patients of an unknown age (under age of 65) who received fluzone high dose in error with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, 3 patients received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE , (lot: UT7729BA ; expiry date: 30-Jun-2023) via unknown route in unknown administration site for prophylactic vaccination (immunization). On an unknown date the 3 residents under the age of 65 received fluzone high dose in error with no reported adverse event (wrong product administered) (latency: unknown). Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481754

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

gering
Staat
MI
Alter
74,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dysphonia Hypersensitivity Throat tightness

Symptomtext

Fluzone High-dose was given at 0905 and pt did start to have an allergic reaction to the vaccine at 0910. Pts voice became very hoarse sounding and pt stated that "I feel like my throat is closing." Pt was given Dexamethasone 4mg IM at 0915 along with Benadryl 50mg IM at 0930. Pt states she felt better. Pts voice to become clear sounding. At about 0950 pt started to sound hoarse again and stated that she felt like her throat was closing again. Pt was given Dexamethasone 4mg IM again at 1005 along with calling 911. Vital signs were taken continuously throughout episode and stable. SpO2 was never <96%. Ambulance came and took pt to ED. Husband was at wife's side throughout and met the ambulance at the hospital. Pt stable when leaving office. Pt was A/O x 4, pt walked from room to stretcher, VVS. Pt denied sob and cp.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dysphonia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
omeprazole
Allergien
Penicillin, cephalosporin, Iodine
Vorherige Impfungen
Pt had anaphylaxis reaction on 1/23/2021to COVID 19 MRNA Pfizer vaccine. Patient was in ER with reaction

VAERS 2465500

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7729BA

gering
Staat
MI
Alter
64,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
20.09.2022
Beginn
22.09.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Administered High Dose flu to individual 64 years old. No adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
not identified by screening checklist
Vorgeschichte
some chronic disease
Andere Medikamente
unknown
Allergien
nka
Vorherige Impfungen
-